Elterman D1, Kaplan S2, Moss J3, Freedman S4, Coutinho K5, Wu N6, Efros M7, D’Anna R8, Padron O9, Robertson K10, Lawindy S11, Mistry S12, Shore N13, Spier J14, Kaminetsky J15, Mazzarella B16, Cahn D17, Jalkut M18, Te A19
1. University of Toronto, Toronto, ON, Canada, 2. Mount Sinai Health System, New York, NY, USA, 3. Oschner LSU Health, Shreveport, LA, USA, 4. Sheldon Freedman Urology, Las Vegas, NV, USA, 5. New Jersey Urology LLC, Millburn, NJ, USA, 6. Comprehensive Urologic Care, Lake Barrington, IL, USA, 7. Accumed Research Associates, Garden City, NY, USA, 8. Arkansas Urology, Little Rock, AR, USA, 9. Florida Urology Partners, Tampa, FL, USA, 10. Chesapeake Urology, Hanover, MD, USA, 11. Advanced Urology Institute, Daytona Beach, FL, USA, 12. North Austin Urology, Austin, TX, USA, 13. Carolina Urologic Research Center, Myrtle Beach, SC, USA, 14. Rio Grande Urology, El Paso, TX, USA, 15. Manhattan Medical Research Center, New York, NY, USA, 16. Urology Austin, Austin, TX, USA, 17. Colorado Clinical Research, Lakewood, CO, USA, 18. Associated Urologists of North Carolina, Raleigh, NC, USA, 19. Weill Medical College of Cornell University, New York, NY, USA
Benign Prostatic Hyperplasia (BPH), Clinical Trial, New Devices, Prospective Study, Bladder Outlet Obstruction